Immunogen | IMGN - 销售收入



销售 更改 日
AbbVie USD 15B 1.62B 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Amgen USD 8.62B 1.28B 2026-03
Astellas Pharma JPY 537.93B 33.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Exelixis USD 610.8M 12.14M 2026-03
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Intrexon USD 717K 511K 2024-06
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
MacroGenics USD 41.23M 31.61M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 13.11B 750M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 12.14B 65M 2026-03